Through expert presentations and collaborative discussions, the symposium provides practical strategies, cutting-edge research, and innovative approaches to improve patient outcomes and advance clinical practice.

As the PICU shifts toward benzodiazepine-sparing strategies to reduce delirium and withdrawal, many centers have embraced alternatives like dexmedetomidine, ketamine, and clonidine. But with rising concerns about polypharmacy, tolerance, and agitation, it's worth asking — have we gone too far? This session will explore evolving sedation practices, pharmacologic risks, and the pharmacist’s role in balancing safety, comfort, and recovery.